Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal contrast-enhanced MRI for cerebrospinal fluid transportation in suspected idiopathic normal pressure hydrocephalus
2020-005542-42Phase 2Active
- Sponsor
- Region Västerbotten
- Start
- Jan 2021
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of gadobutrol in Cerebrospinal fluid circulation disorder and Idiopathic Normal Pressure Hydrocephalus (NPH), sponsored by Region Västerbotten. Started Jan 2021; status: active.
02
Drugs
gadobutrol
03
Conditions
Cerebrospinal fluid circulation disorderIdiopathic Normal Pressure Hydrocephalus (NPH)
Beyond the preview
Go deeper on 2020-005542-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005542-42.